Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Trimegah Bangun Persada Tbk. (NCKL) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Trimegah Bangun Persada Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Trimegah Bangun Persada Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Trimegah Bangun Persada Tbk. trades at Rp885 (market cap 54.26T, 56.47M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Trimegah Bangun Persada Tbk. is far larger — about 4.6× Tempo Scan Pacific Tbk.'s market cap, and Trimegah Bangun Persada Tbk. is more actively traded (56.47M versus 429.7K). Which is the better fit depends on your goals.

NCKLTSPC
Market Cap
54.26T11.68T
Volume
56.47M429.7K
Lot
564.68K4.3K
Turnover
50.19B1.11B
Average Price
888.822,591.65
Value
50.19B1.11B
Indicative Equilibrium Price
8852,580
Indicative Equilibrium Volume
11.61K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NCKL
View details
TSPC
View details

About Trimegah Bangun Persada Tbk.

PT Trimegah Bangun Persada Tbk. (the Company) was established in Indonesia based on Notarial Deed of Erna Priyono, S.H., No. 03 dated September 6, 2004.

Read more on NCKL

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC